Invited
Session 5: Treatment Switching in Oncology Trials
10:10-11:30 AM,
November 23, 2026; Location TBD
Moderator:
Hajime Uno, PhD, Dana-Farber Cancer Institute / Harvard Medical
School
Panelists:
Hiroshi Kuriki, MS, Chugai Pharmaceutical; Mitsuaki Machida, MS,
Shionogi / JPMA; Ray Lin, PhD, Chang Gung University; Hideaki
Takahashi, MD, National Cancer Center Hospital East; Tom Wei-Wu
Chen, MD, National Taiwan University Hospital; May Wang, PhD,
Taiwan Center for Drug Evaluation
Panelist biographies and session details will be posted when
received.